Cargando…

Dilated Cardiomyopathy: A Paradigm of Revolution in Medicine

Detalles Bibliográficos
Autores principales:	Merlo, Marco, Cannatà, Antonio, Sinagra, Gianfranco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7690260/ https://www.ncbi.nlm.nih.gov/pubmed/33105590 http://dx.doi.org/10.3390/jcm9113385

Ejemplares similares

Clinical characterization and natural history of chemotherapy‐induced dilated cardiomyopathy
por: Lalario, Andrea, et al.
Publicado: (2022)

Dilated Cardiomyopathy With Mid‐Range Ejection Fraction at Diagnosis: Characterization and Natural History
por: Gentile, Piero, et al.
Publicado: (2019)

The right ventricular involvement in dilated cardiomyopathy: prevalence and prognostic implications of the often-neglected child
por: Manca, Paolo, et al.
Publicado: (2022)

Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Echocardiographic Advances in Dilated Cardiomyopathy
por: Faggiano, Andrea, et al.
Publicado: (2021)

Sex-Specific Prognostic Implications in Dilated Cardiomyopathy After Left Ventricular Reverse Remodeling
por: Cannata, Antonio, et al.
Publicado: (2020)

Pragmatic electrocardiogram tracings in non-ischaemic dilated cardiomyopathy: diagnostic and prognostic role
por: Pezzato, Andrea, et al.
Publicado: (2023)

Myocarditis evolving in cardiomyopathy: when genetics and offending causes work together
por: Cannata’, Antonio, et al.
Publicado: (2019)

Correction: Diuretic dose trajectories in dilated cardiomyopathy: prognostic implications
por: Nuzzi, Vincenzo, et al.
Publicado: (2022)

Natural History of Dilated Cardiomyopathy in Children
por: Puggia, Ilaria, et al.
Publicado: (2016)

Arrhythmic risk stratification in non-ischaemic dilated cardiomyopathy
por: Del Mestre, Eva, et al.
Publicado: (2023)

Reverse remodeling in Dilated Cardiomyopathy: Insights and future perspectives
por: Merlo, M., et al.
Publicado: (2018)

New perspectives in diagnosis and risk stratification of non-ischaemic dilated cardiomyopathy
por: Pio Loco detto Gava, Carola, et al.
Publicado: (2023)

The promise and challenges of precision medicine in dilated cardiomyopathy
por: Mason, Samantha, et al.
Publicado: (2021)

Role of Titin Missense Variants in Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2015)

Toward a diagnostic CART model for Ischemic heart disease and idiopathic dilated cardiomyopathy based on heart rate total variability
por: Accardo, Agostino, et al.
Publicado: (2022)

Diagnostic yield and predictive value on left ventricular remodelling of genetic testing in dilated cardiomyopathy
por: Bertero, Edoardo, et al.
Publicado: (2023)

Transthyretin amyloid cardiomyopathy: An uncharted territory awaiting discovery
por: Porcari, Aldostefano, et al.
Publicado: (2020)

Persistent Recovery of Normal Left Ventricular Function and Dimension in Idiopathic Dilated Cardiomyopathy During Long‐Term Follow‐up: Does Real Healing Exist?
por: Merlo, Marco, et al.
Publicado: (2015)

Whole Exome Sequencing Identifies a Troponin T Mutation Hot Spot in Familial Dilated Cardiomyopathy
por: Campbell, Nzali, et al.
Publicado: (2013)

Autophagy and Inflammasome Activation in Dilated Cardiomyopathy
por: Caragnano, Angela, et al.
Publicado: (2019)

We need a revolution in medicine
por: Ausman, James I.
Publicado: (2011)

Arrhythmogenic Phenotype in Dilated Cardiomyopathy: Natural History and Predictors of Life‐Threatening Arrhythmias
por: Spezzacatene, Anita, et al.
Publicado: (2015)

Prognostic Significance of Feature-Tracking Right Ventricular Global Longitudinal Strain in Non-ischemic Dilated Cardiomyopathy
por: Cittar, Marco, et al.
Publicado: (2021)

Phenotypic clustering of dilated cardiomyopathy patients highlights important pathophysiological differences
por: Verdonschot, Job A J, et al.
Publicado: (2020)

Risk stratification in cardiomyopathy
por: Sinagra, Gianfranco, et al.
Publicado: (2020)

Plasmid manufacture is the bottleneck of the genetic medicine revolution
por: Ohlson, Jonny
Publicado: (2020)

The Microbiome Revolution: New Insights for Personalized Medicine
por: Laterza, Lucrezia, et al.
Publicado: (2022)

Restrictive cardiomyopathy: definition and diagnosis
por: Rapezzi, Claudio, et al.
Publicado: (2022)

Enhancing risk stratification for life‐threatening ventricular arrhythmias in dilated cardiomyopathy: the peril and promise of precision medicine
por: Asatryan, Babken, et al.
Publicado: (2020)

Genetics of BAG3: A Paradigm for Developing Precision Therapies for Dilated Cardiomyopathies
por: Qu, Hui‐Qi, et al.
Publicado: (2022)

Differences between familial and sporadic dilated cardiomyopathy: ESC EORP Cardiomyopathy & Myocarditis registry
por: Asselbergs, Folkert W., et al.
Publicado: (2020)

FLNC Gene Splice Mutations Cause Dilated Cardiomyopathy
por: Begay, Rene L., et al.
Publicado: (2016)

Modeling Human Dilated Cardiomyopathy Using Humans
por: Gacita, Anthony M., et al.
Publicado: (2018)

The No-Report Paradigm: A Revolution in Consciousness Research?
por: Duman, Irem, et al.
Publicado: (2022)

Precision and genomic medicine for dilated and hypertrophic cardiomyopathy
por: Nomura, Seitaro, et al.
Publicado: (2023)

Global Longitudinal Strain is Incremental to Left Ventricular Ejection Fraction for the Prediction of Outcome in Optimally Treated Dilated Cardiomyopathy Patients
por: Raafs, Anne G., et al.
Publicado: (2022)

Paradigm shift: the Copernican revolution in diverticular disease
por: Zullo, Angelo, et al.
Publicado: (2019)

Prognostic Implications of Left Ventricular Global Longitudinal Strain in Dilated Cardiomyopathy
por: Park, Mi Young
Publicado: (2020)

Synthesis revolution
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_8ckhua3ebljm2va1vd3ql8n873